ETON Historical PE Ratio image   This ETON PE ratio history page last updated 11/11/2022
ETON Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
11/10/2022
2.51-0.12-0.48NA
Q2 2022
8/11/2022
3.01-0.06-0.24NA
Q1 2022
5/12/2022
2.89-0.21-0.84NA
Q4 2021
3/16/2022
3.930.040.1624.6
Q3 2021
11/15/2021
5.11-0.24-0.96NA
Q2 2021
8/16/2021
4.24-0.10-0.40NA
Q1 2021
5/13/2021
7.730.190.7610.2
Q4 2020
3/16/2021
7.92-0.32-1.28NA
Q3 2020
11/12/2020
7.39-0.31-1.24NA
Q2 2020
8/12/2020
6.38-0.23-0.92NA
Q1 2020
5/14/2020
5.20-0.50-2.00NA
Q4 2019
3/5/2020
5.56-0.15-0.60NA
Q3 2019
11/14/2019
6.01-0.28-1.12NA
Q2 2019
8/6/2019
6.02-0.18-0.72NA
Q1 2019
5/7/2019
7.70-0.42-1.68NA
Q4 2018
3/25/2019
7.95-2.24-8.96NA
Q3 2018
12/20/2018
6.09-0.65-2.60NA
ETON PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
11/10/2022
2.51-0.12-0.35NA
Q2 2022
8/11/2022
3.01-0.06-0.47NA
Q1 2022
5/12/2022
2.89-0.21-0.51NA
Q4 2021
3/16/2022
3.930.04-0.11NA
Q3 2021
11/15/2021
5.11-0.24-0.47NA
Q2 2021
8/16/2021
4.24-0.10-0.54NA
Q1 2021
5/13/2021
7.730.19-0.67NA
Q4 2020
3/16/2021
7.92-0.32-1.36NA
Q3 2020
11/12/2020
7.39-0.31-1.19NA
Q2 2020
8/12/2020
6.38-0.23-1.16NA
Q1 2020
5/14/2020
5.20-0.50-1.11NA
Q4 2019
3/5/2020
5.56-0.15-1.03NA
Q3 2019
11/14/2019
6.01-0.28-3.12NA
Q2 2019
8/6/2019
6.02-0.18-3.49NA
Q1 2019
5/7/2019
7.70-0.42NANA
Q4 2018
3/25/2019
7.95-2.24NANA
Q3 2018
12/20/2018
6.09-0.65NANA
Quotes delayed 20 minutes

Email EnvelopeFree ETON Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Eton Pharmaceuticals (ETON) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

ETTX PE Ratio History
EVFM PE Ratio History
EVLO PE Ratio History
EVOK PE Ratio History
EW PE Ratio History
EWTX PE Ratio History
EXAS PE Ratio History
EXEL PE Ratio History
EYE PE Ratio History
EYEG PE Ratio History
How should the ETON historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Eton Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this ETON Historical PE Ratio page.

What is the average historical PE for ETON based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The ETON historical PE ratio using the annualized quarterly earnings method works out to 17.4.

What is the average historical PE for ETON based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The ETON historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the ETON Historical PE Ratio information for Eton Pharmaceuticals' stock. The average ETON historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 17.4. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ETON historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ETON historical PE result, against the recent PE: when this page was posted on 11/10/2022, the most recent closing price for ETON had been 2.51, and the most recent quarterly earnings result, annualized, was 0.16. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent ETON PE on 11/10/2022 based on annualized quarterly EPS was 15.7. Based on ETON's history, that recent PE is low relative to the historical average, with the recent PE 9.8% lower than the historical average PE across our data set for Eton Pharmaceuticals.

For self directed investors doing their due diligence on ETON or any other given stock, valuation analysis for ETON can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Eton Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ETON. Thanks for visiting, and the next time you need to research ETON Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: FFG Price Target, LBRT shares outstanding history, CHWY Insider Buying.

 

ETON Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.